Levobetaxolol HCl

CAS: 116209-55-3

Ref. 3D-REA20955

Produktinformation

• Name: Levobetaxolol HCl
• Synonyme: 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride, (2S)-, 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride, (S)-, Al 1577A, Betaxon, Levobetaxolol hydrochloride, (2S)-1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol hydrochloride (1:1)

Beschreibung

The levorotatory enantiomer of betaxolol, levobetaxolol hydrochloride (LBX), is a beta-adrenergic receptor blocking agent that has been approved for use in pediatric patients and adults. It is currently being investigated as a treatment for cancer and other diseases. Levobetaxolol inhibits the proliferation and migration of cancer cells by inhibiting the activation of the beta-adrenergic receptors located on the surface of these cells. The drug also prevents the proliferation of hematopoietic cells and downregulates insulin resistance. LBX has been shown to have a protective effect on site-specific tissue, such as dental cavity sites, by preventing bacterial colonization.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 343.89 g/mol
• Formel: C₁₈H₂₉NO₃·HCl
• Reinheit: Min. 95%